S

Senseonics Holdings Inc
F:6L6

Watchlist Manager
Senseonics Holdings Inc
F:6L6
Watchlist
Price: 5 EUR -8.26% Market Closed
Market Cap: €2.7B

Net Margin

-217.6%
Current
Declining
by 67.2%
vs 3-y average of -150.4%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-217.6%
=
Net Income
$-63.8m
/
Revenue
$29.3m

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-217.6%
=
Net Income
€-63.8m
/
Revenue
$29.3m

Peer Comparison

Country Company Market Cap Net
Margin
US
Senseonics Holdings Inc
AMEX:SENS
300m USD
Loading...
US
Intuitive Surgical Inc
NASDAQ:ISRG
187.5B USD
Loading...
US
Abbott Laboratories
NYSE:ABT
185.6B USD
Loading...
US
Boston Scientific Corp
NYSE:BSX
139.4B USD
Loading...
US
Stryker Corp
NYSE:SYK
136.7B USD
Loading...
IE
Medtronic PLC
NYSE:MDT
129.6B USD
Loading...
US
Becton Dickinson and Co
NYSE:BDX
57.8B USD
Loading...
DE
Siemens Healthineers AG
XETRA:SHL
47.6B EUR
Loading...
US
IDEXX Laboratories Inc
NASDAQ:IDXX
54.9B USD
Loading...
US
Edwards Lifesciences Corp
NYSE:EW
47.9B USD
Loading...
US
Resmed Inc
NYSE:RMD
37.5B USD
Loading...

Market Distribution

Lower than 88% of companies in the United States of America
Percentile
12th
Based on 15 072 companies
12th percentile
-217.6%
Low
-4 418 600% — -9.6%
Typical Range
-9.6% — 11.3%
High
11.3% — 1 135 400%
Distribution Statistics
the United States of America
Min -4 418 600%
30th Percentile -9.6%
Median 3.1%
70th Percentile 11.3%
Max 1 135 400%

Senseonics Holdings Inc
Glance View

Market Cap
2.7B EUR
Industry
Health Care

Senseonics Holdings, Inc. engages in the design, development, and commercialization of an implantable continuous glucose monitoring system for people with diabetes. The company is headquartered in Germantown, Maryland and currently employs 121 full-time employees. The company went IPO on 2015-03-04. The firm is focused on the development and manufacturing of glucose monitoring products designed to transform lives in the global diabetes community. Its Eversense, Eversense XL, and Eversense E3 continuous glucose monitoring (CGM) systems are designed to continually measure glucose levels in people with diabetes via an under-the-skin sensor, a removable and rechargeable smart transmitter, and a mobile application for real-time diabetes monitoring and management for a period of up to six months. The company is also developing its Gemini product variation to allow for a two-in-one glucose monitoring system combining the functionality of CGM and Flash Glucose Monitoring (FGM), in an implantable sensor that may be utilized with a smart transmitter to get continuous glucose readings and alerts or be utilized through a swipe over the sensor with a smart phone to get on-demand glucose readings without a smart transmitter.

6L6 Intrinsic Value
HIDDEN
Show
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
-217.6%
=
Net Income
$-63.8m
/
Revenue
$29.3m
What is Senseonics Holdings Inc's current Net Margin?

The current Net Margin for Senseonics Holdings Inc is -217.6%, which is below its 3-year median of -150.4%.

How has Net Margin changed over time?

Over the last 3 years, Senseonics Holdings Inc’s Net Margin has decreased from 1 450.2% to -217.6%. During this period, it reached a low of -368.1% on Jun 30, 2023 and a high of 1 450.2% on Sep 30, 2022.

Back to Top